Type 2 Diabetes Mellitus and Altered Immune System Leading to Susceptibility to Pathogens, Especially

Overview

Journal J Clin Med

Specialty General Medicine

Date 2020 Jan 1

PMID 31888124

Citations 70

Authors

Steve Ferlita

Aram Yegiazaryan

Navid Noori

Gagandeep Lal

Timothy Nguyen

Kimberly To

Vishwanath Venketaraman

Affiliations

Soon will be listed here.

Abstract

There has been an alarming increase in the incidence of Type 2 Diabetes Mellitus (T2DM) worldwide. Uncontrolled T2DM can lead to alterations in the immune system, increasing the risk of susceptibility to infections such as . Altered immune responses could be attributed to factors such as the elevated glucose concentration, leading to the production of Advanced Glycation End products (AGE) and the constant inflammation, associated with T2DM. This production of AGE leads to the generation of reactive oxygen species (ROS), the use of the reduced form of nicotinamide adenine dinucleotide phosphate (NADPH) via the Polyol pathway, and overall diminished levels of glutathione (GSH) and GSH-producing enzymes in T2DM patients, which alters the cytokine profile and changes the immune responses within these patients. Thus, an understanding of the intricate pathways responsible for the pathogenesis and complications in T2DM, and the development of strategies to enhance the immune system, are both urgently needed to prevent co-infections and co-morbidities in individuals with T2DM.

Citing Articles

Glycemic Profile and Clinical Treatment in Patients with Diabetes Mellitus-Tuberculosis: An Update Scoping Review.

Rissaadah S, Nursiswati N, Pahria T J Multidiscip Healthc. 2025; 18:747-758.

PMID: 39958764 PMC: 11829731. DOI: 10.2147/JMDH.S510247.

Enhanced mitochondrial function in B cells from elderly type-2 diabetes mellitus patients supports intrinsic inflammation.

Frasca D, Bueno V Front Aging. 2024; 5:1444527.

PMID: 39247900 PMC: 11377412. DOI: 10.3389/fragi.2024.1444527.

Impact of hyperglycemia on tuberculosis treatment outcomes: a cohort study.

Yanqiu X, Yang Y, Xiaoqing W, Zhixuan L, Kuan Z, Xin G Sci Rep. 2024; 14(1):13586.

PMID: 38866898 PMC: 11169383. DOI: 10.1038/s41598-024-64525-3.

The American Association of Tissue Banks tissue donor screening for Mycobacterium tuberculosis-Recommended criteria and literature review.

Greenwald M, Edwards N, Eastlund D, Gurevich I, Ho A, Khalife G Transpl Infect Dis. 2024; 26 Suppl 1:e14294.

PMID: 38852068 PMC: 11578281. DOI: 10.1111/tid.14294.

COVID-19 and Comorbidities: What Has Been Unveiled by Metabolomics?.

Camelo A, Zamora Obando H, Rocha I, Dias A, Mesquita A, Simionato A Metabolites. 2024; 14(4).

PMID: 38668323 PMC: 11051775. DOI: 10.3390/metabo14040195.

References

Chesdachai S, Zughaier S, Hao L, Kempker R, Blumberg H, Ziegler T . The Effects of First-Line Anti-Tuberculosis Drugs on the Actions of Vitamin D in Human Macrophages. J Clin Transl Endocrinol. 2017; 6:23-29. PMC: 5242622. DOI: 10.1016/j.jcte.2016.08.005. View

Kumar N, Sridhar R, Banurekha V, Jawahar M, Fay M, Nutman T . Type 2 diabetes mellitus coincident with pulmonary tuberculosis is associated with heightened systemic type 1, type 17, and other proinflammatory cytokines. Ann Am Thorac Soc. 2013; 10(5):441-9. PMC: 3960913. DOI: 10.1513/AnnalsATS.201305-112OC. View

Lagman M, Ly J, Saing T, Kaur Singh M, Tudela E, Morris D . Investigating the causes for decreased levels of glutathione in individuals with type II diabetes. PLoS One. 2015; 10(3):e0118436. PMC: 4366217. DOI: 10.1371/journal.pone.0118436. View

Lin P, Plessner H, Voitenok N, Flynn J . Tumor necrosis factor and tuberculosis. J Investig Dermatol Symp Proc. 2007; 12(1):22-5. DOI: 10.1038/sj.jidsymp.5650027. View

Wilcox G . Insulin and insulin resistance. Clin Biochem Rev. 2005; 26(2):19-39. PMC: 1204764. View

Cooper A, Mayer-Barber K, Sher A . Role of innate cytokines in mycobacterial infection. Mucosal Immunol. 2011; 4(3):252-60. PMC: 3294290. DOI: 10.1038/mi.2011.13. View

Flynn J, Chan J . Immunology of tuberculosis. Annu Rev Immunol. 2001; 19:93-129. DOI: 10.1146/annurev.immunol.19.1.93. View

Nowotny K, Jung T, Hohn A, Weber D, Grune T . Advanced glycation end products and oxidative stress in type 2 diabetes mellitus. Biomolecules. 2015; 5(1):194-222. PMC: 4384119. DOI: 10.3390/biom5010194. View

Oates P . Aldose reductase, still a compelling target for diabetic neuropathy. Curr Drug Targets. 2008; 9(1):14-36. DOI: 10.2174/138945008783431781. View

10.

Oka M, Kato N . Aldose reductase inhibitors. J Enzyme Inhib. 2002; 16(6):465-73. DOI: 10.1080/14756360127568. View

11.

Boom W, Canaday D, Fulton S, Gehring A, Rojas R, Torres M . Human immunity to M. tuberculosis: T cell subsets and antigen processing. Tuberculosis (Edinb). 2003; 83(1-3):98-106. DOI: 10.1016/s1472-9792(02)00054-9. View

12.

Garg S, Yan Z, Vitvitsky V, Banerjee R . Differential dependence on cysteine from transsulfuration versus transport during T cell activation. Antioxid Redox Signal. 2010; 15(1):39-47. PMC: 3110100. DOI: 10.1089/ars.2010.3496. View

13.

Hewison M . Vitamin D and the intracrinology of innate immunity. Mol Cell Endocrinol. 2010; 321(2):103-11. PMC: 2854233. DOI: 10.1016/j.mce.2010.02.013. View

14.

Trinchieri G . Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol. 2003; 3(2):133-46. DOI: 10.1038/nri1001. View

15.

Wickremasinghe M, Thomas L, Friedland J . Pulmonary epithelial cells are a source of IL-8 in the response to Mycobacterium tuberculosis: essential role of IL-1 from infected monocytes in a NF-kappa B-dependent network. J Immunol. 1999; 163(7):3936-47. View

16.

Sutaria N, Liu C, Chen T . Vitamin D Status, Receptor Gene Polymorphisms, and Supplementation on Tuberculosis: A Systematic Review of Case-Control Studies and Randomized Controlled Trials. J Clin Transl Endocrinol. 2015; 1(4):151-160. PMC: 4295520. DOI: 10.1016/j.jcte.2014.08.001. View

17.

Afzali B, Mitchell P, Lechler R, John S, Lombardi G . Translational mini-review series on Th17 cells: induction of interleukin-17 production by regulatory T cells. Clin Exp Immunol. 2009; 159(2):120-30. PMC: 2810380. DOI: 10.1111/j.1365-2249.2009.04038.x. View

18.

Domingo-Gonzalez R, Prince O, Cooper A, Khader S . Cytokines and Chemokines in Mycobacterium tuberculosis Infection. Microbiol Spectr. 2016; 4(5). PMC: 5205539. DOI: 10.1128/microbiolspec.TBTB2-0018-2016. View

19.

Franklin C, Rosenfeld-Franklin M, White C, Kavanagh T, Fausto N . TGFbeta1-induced suppression of glutathione antioxidant defenses in hepatocytes: caspase-dependent post-translational and caspase-independent transcriptional regulatory mechanisms. FASEB J. 2003; 17(11):1535-7. DOI: 10.1096/fj.02-0867fje. View

20.

Verhasselt V, Vanden Berghe W, Vanderheyde N, Willems F, Haegeman G, Goldman M . N-acetyl-L-cysteine inhibits primary human T cell responses at the dendritic cell level: association with NF-kappaB inhibition. J Immunol. 1999; 162(5):2569-74. View